These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 1373799
1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Begleiter A, Robotham E, Leith MK. Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799 [Abstract] [Full Text] [Related]
2. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Begleiter A, Leith MK. Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273 [Abstract] [Full Text] [Related]
3. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A. Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [Abstract] [Full Text] [Related]
4. Activity of quinone alkylating agents in quinone-resistant cells. Begleiter A, Leith MK. Cancer Res; 1990 May 15; 50(10):2872-6. PubMed ID: 1692249 [Abstract] [Full Text] [Related]
5. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts. Halinska A, Belej T, O'Brien PJ. Br J Cancer Suppl; 1996 Jul 15; 27():S23-7. PubMed ID: 8763840 [Abstract] [Full Text] [Related]
6. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Siegel D, Gibson NW, Preusch PC, Ross D. Cancer Res; 1990 Dec 01; 50(23):7483-9. PubMed ID: 1701346 [Abstract] [Full Text] [Related]
7. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]. Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T. Gan To Kagaku Ryoho; 1993 Jun 01; 20(8):1037-41. PubMed ID: 7685584 [Abstract] [Full Text] [Related]
8. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents. Begleiter A, Leith MK, McClarty G, Beenken S, Goldenberg GJ, Wright JA. Cancer Res; 1988 Apr 01; 48(7):1727-35. PubMed ID: 3127038 [Abstract] [Full Text] [Related]
9. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW, Ross D. Cancer Res; 1994 Jun 15; 54(12):3196-201. PubMed ID: 8205540 [Abstract] [Full Text] [Related]
10. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Keyes SR, Fracasso PM, Heimbrook DC, Rockwell S, Sligar SG, Sartorelli AC. Cancer Res; 1984 Dec 15; 44(12 Pt 1):5638-43. PubMed ID: 6437671 [Abstract] [Full Text] [Related]
12. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C. Saeki S, Nishiyama M, Toge T. Hiroshima J Med Sci; 1995 Sep 15; 44(3):55-63. PubMed ID: 8567314 [Abstract] [Full Text] [Related]
14. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines. Lambert PA, Kang Y, Greaves B, Perry RR. J Surg Res; 1998 Dec 15; 80(2):177-81. PubMed ID: 9878310 [Abstract] [Full Text] [Related]